RUNX2: A Master Bone Growth Regulator That May Be Involved in the DNA Damage Response

Area of Science:

• Molecular Biology
• Cell Biology
• Developmental Biology

Background:

• RUNX2 is a critical transcription factor for osteoblast proliferation and differentiation in bone formation.
• RUNX2 levels fluctuate during the cell cycle and can impact cell cycle progression.
• Emerging evidence suggests RUNX2's involvement in cancer and genomic instability.

Purpose of the Study:

• To investigate the role of RUNX2 in the cellular DNA damage response (DDR).
• To understand RUNX2's function in differentiating cells, especially during osteogenesis under oxidative stress.
• To elucidate the mechanism of RUNX2's involvement in DDR.

Main Methods:

• Analysis of RUNX2 expression patterns during the cell cycle.
• Investigating RUNX2 interactions with proteins like p53 and histone deacetylases.
• Assessing the impact of RUNX2 modifiers on preosteoblast sensitivity to oxidative stress-induced DNA damage.

Main Results:

• RUNX2's cellular levels exhibit cell phase-specific oscillations.
• RUNX2 overexpression can impede G1 to S phase progression in osteoblasts.
• RUNX2 modifiers alter the sensitivity of differentiating preosteoblasts to oxidative DNA damage.

Conclusions:

• RUNX2 is implicated in the cellular DNA damage response (DDR).
• RUNX2's role in DDR is crucial for osteogenesis, which involves oxidative stress.
• The precise function of RUNX2 in DDR within differentiating cells remains an open question.